Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-012949
Filing Date
2024-02-08
Accepted
2024-02-08 19:11:37
Documents
2
Period of Report
2024-02-08

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 2141
2 EX-24 mgx-ex24.htm EX-24 12987
  Complete submission text file 0000950170-24-012949.txt   16647
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799
Business Address
Dere Willard H (Reporting) CIK: 0001311569 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41949 | Film No.: 24610732

Mailing Address 5959 HORTON STREET 7TH FLOOR EMERYVILLE CA 94608
Business Address 5959 HORTON STREET 7TH FLOOR EMERYVILLE CA 94608 (510) 871-4880
Metagenomi, Inc. (Issuer) CIK: 0001785279 (see all company filings)

EIN.: 813909017 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)